Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 285Head and Neck Neoplasms 250Carcinoma, Non-Small-Cell Lung 95Thyroid Neoplasms 92Melanoma 68Mouth Neoplasms 67Nasopharyngeal Carcinoma 64Oropharyngeal Neoplasms 63Breast Neoplasms 54Colorectal Neoplasms 49Lung Neoplasms 47Ovarian Neoplasms 45Neoplasm Metastasis 45Neoplasms 41Uterine Cervical Neoplasms 39Carcinoma, Squamous Cell 39Carcinoma, Renal Cell 34Triple Negative Breast Neoplasms 31Stomach Neoplasms 31Laryngeal Neoplasms 31Endometrial Neoplasms 29Carcinoma 29Sarcoma 28Esophageal Neoplasms 28Pancreatic Neoplasms 27Salivary Gland Neoplasms 26Prostatic Neoplasms 25Thyroid Cancer, Papillary 23Urinary Bladder Neoplasms 22Hypopharyngeal Neoplasms 22

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Head & Neck × 90 days × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡